U.S., Feb. 11 -- An application to own the trademark for 'KENLIFABI' has been filed on Aug. 27, 2025.
Owner(s):
Idorsia Pharmaceuticals Ltd; Hegenheimermattweg 91, , SWITZERLAND
Goods and/or Services:
For: Pharmaceutical preparations for human use for the treatment of Fabry disease and symptoms and sequelae of Fabry disease, for the treatment of glycolipid storage disorders, and for the treatment of cancer
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2026-02-10&serialNumber=99360014
Disclaimer: Curated by HT Syndication....